The receptors erbB-3 and erbB-4 are members of the type 1
tyrosine kinase receptor family which also comprises
epidermal growth factor receptor (
EGF-R) and erbB-2. ErbB-3 and erbB-4 receptors are known to bind a family of related
proteins termed heregulins. In this study, we report differential expression of P185erbB-2, P160erbB-3 and P180erbB-4, and their
ligand heregulin alpha, in normal bronchial epithelial, and
non-small cell lung carcinoma (NSCLC) cell lines. Expression of P185erbB-2 and P160erbB-3 vary from very low to a high level in NSCLC cell lines and a low level in normal bronchial cells. In contrast, P180erbB-4 was detected only in NSCLC cell lines but not in normal bronchial cells.
Heregulin alpha is expressed at intermediate levels in the normal and
cancer cell lines studied. Immunoprecipitation, using
antibodies to erbB-2, erbB-3 or erbB-4 receptors, coupled to
phosphotyrosine Western blot analysis indicates that these three receptors are constitutively
tyrosine phosphorylated in
lung cancer cell lines, but only erbB-2 and erbB-3 are autophosphorylated in normal cells. These data suggest that constitutive activation of erbB-2, erbB-3 and erbB-4 receptors could be induced by
heregulin alpha via an autocrine loop mechanism, and that the active forms of erbB-4 may cooperate with the other members of the
EGF-receptor family in human lung
carcinogenesis.